This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.

Dr. Adriana Di Polo Awarded the 2019 Shaffer Prize from Glaucoma Research Foundation

Dr. Di Polo’s laboratory investigated the hypothesis that insulin can improve the survival and function of injured retinal ganglion cells and may be viable as an innovative glaucoma treatment.

Catalyst for a Cure: A Clear Path to Vision Restoration

For the first time, thanks to improvements in how we measure the disease, researchers are studying and testing new therapeutic candidates for neuroprotection, neuroenhancement, and visual restoration.

2018 Weston Lecture by Jeffrey Goldberg, MD, PhD

Listen to the 2018 Weston Glaucoma Research Lecture delivered by Jeffrey Goldberg, MD, PhD, a principal investigator in the Catalyst for a Cure.

Rare Forms of Glaucoma

Although primary open-angle glaucoma is the most common type of glaucoma, there are many other types of eye disorders that fall under the spectrum of glaucoma.

Glaucoma and Reading Ability

What can be done to make reading easier for those with glaucoma? You can start by trying some things on your own.

New Priorities for Glaucoma Research

New approaches to treating, managing, and even curing glaucoma are essential to patients and caregivers. Researchers are actively working to advance the field in several key areas.

Impact of GRF Shaffer Grants: Funding Important Research Discoveries

Research outcomes from past Shaffer Grant recipients demonstrate the impact of this funding in catalyzing the growth, sustainability, and productivity of glaucoma research laboratories across the US.

Recall: CyPass Micro-Stent Withdrawn Amid Concerns of Endothelial Cell Loss

August 29, 2018 — Alcon has issued a voluntary global recall of the CyPass microstent, effective immediately.

Carla Siegfried, MD: Innovative Glaucoma Research

“I became interested in glaucoma because I liked the long-term aspect of it. It is through that long-term relationship that we can really get to know our patients and help them.” — Carla Siegfried, MD

Glaucoma Research Foundation Grant Leads to Major Breakthrough in Neuron Regeneration

Study indicates treatment using insulin may restore vision in glaucoma patients.

Impact of GRF Shaffer Grants: Catalyzing the Careers of Glaucoma Researchers

Glaucoma Research Foundation Shaffer Grants present a unique opportunity for investigators to pursue innovative ideas in the spirit of high risk/high reward scientific discovery.

President’s Report from ARVO 2018

ARVO is the annual meeting of the Association for Research in Vision and Ophthalmology.

Niki’s Story: Putting a Positive Spin on her Glaucoma

“Whatever curves life throws at us, I believe one must always make the best out of a situation; there is always a positive side.” – Niki De Lara

New Drug Rhopressa Now Available for Open-Angle Glaucoma

Rhopressa 0.02% is a novel once-daily eye drop for lowering elevated intraocular pressure.

Generic Medications: Are They the Same?

Generic drugs work well for most patients, but there are differences compared to the brand name products.

Glaucoma and Driving Ability

Concerns about driving often come up with glaucoma and may be brought to the doctor’s attention by the patient or a family member.

Tips on Transferring Your Eye Care to a New Doctor

What will your new doctor need to know to take over management and treatment of your glaucoma?

Genetic Testing in Glaucoma

Glaucoma is a complex disease resulting from a mix of genetic and environmental factors. Family history is an important risk factor for glaucoma.

Dr. James Brandt on New Horizons in Glaucoma Drug Delivery

James D. Brandt, MD co-moderated the session “New Horizons in Glaucoma Drug Delivery” with Anne L. Coleman, MD, PhD at the 7th annual Glaucoma 360 New Horizons Forum in San Francisco.

Catalyst for a Cure 2018 Research Progress Report

Biomarkers can provide physicians with better tools to diagnose and manage glaucoma before vision is lost, as well as accelerate better treatments for glaucoma.

Dr. Janey Wiggs: Update on Genetic Research for Glaucoma

We talked with Dr. Janey Wiggs, a scientific advisor for Glaucoma Research Foundation, at the AAO 2017 meeting in New Orleans about what’s new in genetic research for treating glaucoma.

Eye Anatomy

To understand glaucoma, it is important to have an idea of how the eye works and the different parts of the eye.

Glaucoma Worldwide: A Growing Concern

The worldwide prevalence of glaucoma is increasing. This is due in part to the rapidly aging population.

Cataracts and Glaucoma

Both cataracts and glaucoma can be a natural part of the aging process. Many people over 60 may have both.

How to Know If You’re at Risk for Glaucoma

One way to help prevent vision loss from glaucoma is to make sure you get regular eye examinations. Early diagnosis and treatment is critical to preserving sight.